This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Moma Therapeutics. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael H Reutershan: Innovator in Spleen Tyrosine Kinase Inhibition
Introduction
Michael H Reutershan is a notable inventor based in the United States. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target specific enzymes.
Latest Patents
Michael H Reutershan holds a patent for "Aminopyrimidines As Syk Inhibitors." This invention provides novel pyrimidine amines of formula (Ib), which are potent inhibitors of spleen tyrosine kinase. These compounds may be useful in the treatment and prevention of diseases mediated by this enzyme, such as asthma, COPD, and rheumatoid arthritis.
Career Highlights
Throughout his career, Michael H Reutershan has focused on innovative approaches to drug development. His work has contributed to advancements in therapeutic options for various diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Michael has collaborated with notable coworkers, including Michael D Altman and Brian M Andresen. These partnerships have enhanced the research and development process, leading to more effective solutions in the field of medicinal chemistry.
Conclusion
Michael H Reutershan is a dedicated inventor whose work in enzyme inhibition has the potential to impact the treatment of several significant health conditions. His contributions to the field are noteworthy and reflect his commitment to innovation in medicine.